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Natural killer (NK) cells play a key role in the immune response to certain infections andmalignancies
bydirect cytolysis of infected or transformedcells andby secretionof potent immunemediators. NK
cells express an array of activating receptors that recognize self-molecules. If not restrained by
inhibitory receptors recognizing major histocompatibility complex (MHC) class I proteins on the
surface of self cells, NK cells are able to kill normal, healthy cells. Not all NK cells express inhibitory
receptors for self-MHC class I; thus, other tolerance mechanisms are necessary to prevent NK cell-
mediated autoimmunity. Here we review themajor mechanisms of NK cell education and tolerance.Natural killer (NK) cells are the third population of lymphoid cells
that, unlike T and B cells, do not express receptors that require
somatic gene rearrangements to generate receptor diversity
and specificity. Instead, NK cell functions are controlled by
a wide array of germline-encoded inhibitory and activating
receptors, many of which are expressed in a stochastic, varie-
gated pattern, resulting in many subsets of functionally distinct
NK cells. Although normally classified as part of the innate
immune system due to the lack of receptor gene rearrangement,
it has recently been appreciated that NK cells exhibit many
features normally associated with adaptive immunity. These
include the expansion of pathogen-specific cells, the generation
of long-lasting ‘‘memory’’ cells that persist after cognate antigen
encounter, and the ability to mount an enhanced secondary
recall response to rechallenge (Sun et al., 2009). Although NK
cell-associated receptors have been implicated in certain auto-
immune diseases (Gur et al., 2010; Martin et al., 2002; Name-
kawa et al., 2000; Yen et al., 2001), and NK cells may alter
T cell-mediated autoimmunity (Feuerer et al., 2009; Lu et al.,
2007; Poirot et al., 2004; Shi et al., 2000), as yet there is no
evidence that NK cells alone are able to directly cause autoim-
munity. Even on autoimmune-prone genetic backgrounds such
as NOD, autoimmune disease is not observed in these mouse
strains in the absence of B cells and T cells. Thus, NK cell educa-
tion and tolerance appear to be more effective than either the
central or peripheral tolerance mechanisms governing T cells
and B cells that can fail, causing autoimmunity.
Many of the activating or coactivating NK cell receptors
expressed by mouse and human NK cells recognize self-anti-
gens (Table 1). For example, the activating NKG2D receptor
recognizes numerous self-ligands in the host. Several of the acti-
vating Killer-cell Immunoglobulin-like Receptor (KIR), Ly49, and
CD94-NKG2C receptors are capable of recognizing self-major
histocompatibility complex (MHC) class I proteins, andmembers
of the ‘‘natural cytotoxicity receptors’’ group (such as NKp30,
NKp44, and NKp46) appear able to bind as yet undefined self-
ligands in the host (Lanier, 2008;Moretta et al., 2001). In addition,
several ‘‘coactivating’’ receptors have been identified on NKcells, such as CD2, LFA-1, CD244 (2B4), and CD226 (DNAM-1),
which also recognize self-ligands that are broadly distributed on
many tissues in the host (Lanier, 2008). Thus, NK cells express
many activating receptors for self that could potentially drive
autoreactivity.
NK Cell Receptors for MHC Class I
Although NK cells express a wide variety of inhibitory receptors
that recognize diverse self-molecules to prevent autoaggres-
sion, inhibitory NK receptors recognizing self-MHC class I are
considered to be the predominant mechanism responsible for
NK cell tolerance to self. This is most dramatically demonstrated
by the ability of NK cells in wild-type, healthy mice to rapidly
reject splenocytes or bone marrow from syngeneic mice lacking
the MHC component b2-microglobulin (b2 m, an MHC compo-
nent), MHC class I heavy chains, or TAP-1 (Bix et al., 1991;
Dorfman et al., 1997; Liao et al., 1991; Ljunggren et al., 1994).
This finding implies that healthy hematopoietic cells from wild-
type mice constitutively express ligands for activating NK recep-
tors that can initiate a strong NK cell response, if not restrained
by the expression of MHC class I on healthy lymphoid or myeloid
cells (Dong et al., 2009).
Three families of NK receptors recognize MHC class I: the
primate KIR, the murine Ly49 receptors, and the CD94-NKG2
receptors in both rodents and primates. All three gene families
encode both inhibitory and activating family members (Long,
2008). The activating receptors in the human KIR and murine
Ly49 families arose by gene duplication and conversion from
inhibitory receptors (Abi-Rached and Parham, 2005), such that
the extracellular domains of these activating receptors are highly
homologous to their inhibitory counterparts (Figure 1A). There-
fore, several of the activating KIR and Ly49 receptors have the
ability to bind with low affinity to MHC class I ligands.
All of the inhibitory receptors in humans and rodents contain
one or more intracellular immunoreceptor tyrosine-based inhib-
itory motifs (ITIM), which are characterized by the signature
sequence (I/L/V/S)xYxx (L/V) (where x represents any amino
acid, and slashes separate alternative amino acids that mayCell 142, September 17, 2010 ª2010 Elsevier Inc. 847
Table 1. Activating and Coactivating NK Cell Receptors
Gene Common Name Species Ligand
Klra4 Ly49D Mouse H-2Dd
Hamster MHC I
Klra8 Ly49H Mouse MCMV-m157
Klra16 Ly49P Mouse MCMV
Klrb1c NK1.1, NKR-P1C Mouse Unknown
Klrb1f NKR-P1F Mouse Clrg
Pilrb1 PILRb Mouse O-glycosylation
CD99
CD244 2B4 Human CD48
ITGAL LFA-1, CD11a Mouse,
human
ICAM-1, 2, 3
KLRD1-KLRC2, 3 CD94-NKG2C, E Mouse,
human
Mouse Qa-1b
Human HLA-E
KLRK1 NKG2D Mouse,
human
Mouse Rae-1,
H60, MULT1
Human MICA,
MICB, ULBP1-6
CD2 LFA-2 Human CD58
KLRF2 NKp65 Human KACL
KLRF1 NKp80 Human AICL
NCR1 NKp46 Mouse,
human
hemagglutinin
NCR2 NKp44 Human Unknown
NKC3 NKp30 Human B7-H6
KIR2DS CD158 Human HLA class I
KIR3DS CD158 Human HLA class I
FCGR3 CD16 Mouse,
human
IgG
CD226 DNAM-1 Mouse,
human
CD112, CD155
SLAMF7 CRACC Human CRACC
SLAMF6 NTB-A Human NTB-Aoccupy a given position). Many of the activating receptors lack
intracellular signaling motifs but instead noncovalently associate
via a charged residue in the receptor transmembrane domain
with the immunoreceptor tyrosine-based activating motif
(ITAM)-containing adapters DAP12, Fc3RIg, or CD3z, which
recruit and activate the Syk or ZAP70 tyrosine kinases, or in
some cases the DAP10 adaptor, which induces PI3-kinase
signaling (Figure 1A). With a few exceptions, human KIRs contain
either two (KIR2D) or three (KIR3D) immunoglobulin (Ig)-like
domains in the extracellular domain and are designated as
KIR2DL or KIR3DL, respectively, if they possess a long cyto-
plasmic domain containing ITIM. KIR2DS or KIR3DS have short
cytoplasmic domains lacking ITIM but possess charged resi-
dues in their transmembrane regions to allow for association
with DAP12 or Fc3RIg. KIR2D receptors typically recognize
human leukocyte antigen -C (HLA-C) alleles, whereas KIR3D
receptors recognize HLA-B or some HLA-A alleles. The NKG2
family contains one inhibitory family member, NKG2A, and two
activating members, NKG2C and NKG2E. The inhibitory CD94-
NKG2A and the activating CD94-NKG2C receptors both recog-848 Cell 142, September 17, 2010 ª2010 Elsevier Inc.nize MHC class Ib molecules, either HLA-E in humans or its
ortholog Qa-1 in mice (Lanier, 2005). In humans, a subset of
NK cells express another KIR-related inhibitory receptor, LILRB1
(also designated LIR-1, CD85j, or ILT2), which recognizes
a shared epitope present in all human MHC class I proteins
(Chapman et al., 1999).
Chronic Exposure to Activating Ligands Tolerizes
NK Cells
Given the existence of numerous activating receptors that can
interact with host-encoded ligands, how do NK cells avoid
causing autoimmunity? In mice, the Rae-1 family of NKG2D
ligands is constitutively expressed in the embryo but is silenced
before birth and is not expressed or is expressed in only low
amounts in healthy adult tissues. Immunocompetent adult
mice reject transplanted tumors expressing NKG2D ligands
and eliminate virus-infected cells in which NKG2D ligands are
induced (Cerwenka et al., 2001; Champsaur and Lanier, 2010;
Diefenbach et al., 2001; Lodoen et al., 2003, 2004). NK cells effi-
ciently reject adoptively transferred syngeneic hematopoietic
cells from mice constitutively expressing a Raet1 transgene,
encoding a ligand for the activating NKG2D receptor. These find-
ings indicate that NK cells have the capacity to recognize and
attack otherwise normal, healthy cells if they express NKG2D
ligands (Ogasawara et al., 2005; Oppenheim et al., 2005). In
contrast, NK cells in Rae-1 transgenic mice do not attack Rae-
1-bearing tissues and are unable to reject transplanted tumors
expressing NKG2D ligands (Champsaur and Lanier, 2010).
Thus, when NK cells develop in the continuous presence of
NKG2D ligands they tolerate cells expressing these ligands,
due to both the downregulation of the NKG2D receptor on
the NK cells as well as hyporesponsiveness to NKG2D signaling
(Champsaur and Lanier, 2010). Studies examining NK cells
from transgenic mice constitutively expressing Rae-1 have
found that activating NK receptors other than NKG2D may or
may not be impaired depending on the particular ligand
expressed, its distribution, and its abundance (Champsaur
et al., 2010; Ogasawara et al., 2005; Oppenheim et al., 2005;
Wiemann et al., 2005). In vitro coculture of mouse NK cells
with NKG2D ligand-bearing tumors can also desensitize other
activating receptors on the NK cells (Coudert et al., 2008).
The activating Ly49D receptor recognizes H-2Dd, and NK cells
from mice lacking H-2Dd are able to kill H-2Dd-bearing targets
via Ly49D. Conversely, NK cells from H-2Dd-expressing mice
are unable to kill H-2Dd target cells via Ly49D, demonstrating
that NK cells with this self-reactive activating receptor are func-
tionally tolerant when the NK cells develop in the presence of the
ligand (George et al., 1999). Although themolecular mechanisms
of this tolerance or receptor anergy are undefined, it has been
suggested that it is mediated by the coexpression of the
H-2Dd-reactive inhibitory receptors Ly49A and Ly49G2 (George
et al., 1999). Similarly, there is no direct evidence that human NK
cells expressing activating KIR with the ability to recognize
self-HLA-C ligands cause autoimmunity in these individuals,
although a genetic association between activating KIR and
certain autoimmune diseases has been reported but might be
caused by expression of activating KIR on T cells (Kulkarni
et al., 2008).
Figure 1. Evolutionary Origins of Nonautoreactive Activating Receptors
(A) New activating receptors for natural killer cells are generated by duplication of an inhibitory receptor gene and the subsequent conversion to an activating
receptor. This conversion occurs when the exons for the transmembrane (TM) and intracellular domains are exchanged with those of an activating receptor
by crossover events. If the new activating receptor is specific for self-major histocompatibility complex (MHC) class I, it might cause autoimmunity and be
selected against.
(B) Inhibitory receptors that are specific for bothMHCclass I and pathogen-encoded ligands have also been converted to activating receptors. Subsequent muta-
tions have eliminated the specificity for MHC class I and retained specificity for the pathogen-encoded ligand.Another activating Ly49 receptor, Ly49H, recognizes a mouse
cytomegalovirus (MCMV)-encoded glycoprotein, m157, but
does not recognize host MHC class I ligands (Arase et al.,
2002; Smith et al., 2002). MCMV m157 also binds the inhibitory
Ly49I receptor and thus likely evolved to inhibit NK cell
responses to MCMV infection. The gene encoding Ly49H arose
from the duplication of the gene encoding Ly49I and conversion
to an activating receptor by swapping the ITIM-bearing domain
for a charged transmembrane domain (Figure 1B). Although
beneficial for controlling MCMV, this Ly49H precursor might
have potentially been autoreactive due to its specificity for
MHC class I. Further selection events eliminated this self-reac-
tivity, while retaining MCMV specificity (Figure 1B). Whereas
Ly49H-expressing NK cells from wild-type mice respond
robustly when they encounter MCMV-infected cells, ubiquitous
transgenic or retroviral expression of m157 in mice renders the
Ly49H-expressing NK cells unresponsive to Ly49H stimulation
(Sun and Lanier, 2008b; Tripathy et al., 2008). This is caused,
in part, by downmodulation of the Ly49H receptor on the NK
cells encountering m157 during development, but also by hypo-
responsiveness of receptor signaling. Whether or not chronic
stimulation through Ly49H affects signaling through other acti-
vating receptors may depend on the amount of ligand expressedor the anatomical location of the expressed ligand (Sun and
Lanier, 2008b; Tripathy et al., 2008). In these systems, anergy
is induced in NK cells transferred from non-m157-expressing
hosts into the transgenic animal, indicating that anergy can be
induced in mature NK cells (Tripathy et al., 2008). The m157
did not need to be expressed by the developing NK cells them-
selves as expression of m157 in trans is sufficient to impair
Ly49H functions (Sun and Lanier, 2008b). Collectively, these
studies demonstrate that NK cells, like T cells, achieve a state
of tolerance when they are chronically exposed to endogenous,
as well as foreign, ligands recognized by their activating recep-
tors. Unlike T cells, which only express a single dominant-acti-
vating receptor, chronic exposure to one activating ligand may
tolerize NK responses only to the cognate receptor or alterna-
tively to other activating receptors on the same cells, depending
on the system. The mechanisms of this receptor-proximal toler-
ance and whole-cell anergy are not yet defined.
Do NK Cells Undergo Selection of Inhibitory Receptor
Repertoires?
The inhibitory KIR and Ly49 receptors recognize polymorphic
variants on their MHC class I ligands. Within the total NK cell
population, the inhibitory receptors for MHC class I areCell 142, September 17, 2010 ª2010 Elsevier Inc. 849
expressed in a variegated manner on overlapping subsets of NK
cells. Moreover, the inhibitory KIR and Ly49 receptors them-
selves are highly polymorphic and have differing affinities for
their MHC class I ligands (Carlyle et al., 2008; Hanke et al.,
1999; Parham, 2008). These features, as well as the fact that
the NK receptors and their MHC class I ligands are not geneti-
cally linked, result in a situation where some NK cells in the
host do not express an inhibitory receptor for any self-MHC class
I protein. Indeed, we now appreciate that in some individuals
a significant proportion of NK cells fail to express inhibitory
receptors reactive with the polymorphic MHC class I molecules
that they have inherited (Fernandez et al., 2005; Yawata et al.,
2008). Yet, these individuals do not suffer from autoimmune
attack by their NK cells, raising the question of howNKcells lack-
ing self-MHC class I inhibitory receptors achieve tolerance.
Some strains of rodents possess 20 or more Ly49 genes and
some humans possess 15 KIR genes, providing for considerable
receptor diversity within the NK cell population. Expression of
these receptors appears stochastic and NK cells can express
many KIR or Ly49 receptors that do not bind to self-MHC
class I ligands in the host. Therefore, the presence of a MHC
class I ligand is not required for NK cells to stably express a given
Ly49 or KIR on a substantial subset of cells. In addition, NK cells
expressing an activating KIR or Ly49 receptor that is able to
bind MHC class I, in general, are not deleted or preferentially
expanded in a host possessing a reactive MHC class I allele.
Therefore, unlike in T cells, there is no evidence for either strong
positive or negative selection of NK cells with respect to the acti-
vating KIR or Ly49 receptors.
Nonetheless, the expression of self-ligands for the inhibitory
NK receptors for MHC class I does influence the development
of NK cells. The frequency of NK cells expressing multiple inhib-
itory receptors can be approximately predicted by multiplying
the frequency of NK cells expressing each inhibitory receptor
(Raulet et al., 1997; Valiante et al., 1996). Although this ‘‘product
rule’’ roughly holds for MHC class I-deficient mouse models,
expression of two or more inhibitory receptors for self-MHC
class I occurs less frequently than would be expected in MHC
class I-sufficient mice. In fact, the frequency of NK cells express-
ing MHC class I-reactive inhibitory receptors is higher in MHC
class I-deficient animals than in MHC class I-sufficient animals
(Held et al., 1996; Salcedo et al., 1997). Thus, it appears that
there is a selective or educational event that limits the expression
of two ormore inhibitory receptors for self-MHCclass I on a given
NK cell. The expression of MHC class I on both hematopoietic
and nonhematopoietic cells influences the development of the
inhibitory Ly49 repertoire (Roth et al., 2000; Sykes et al., 1993).
Transgenic expression of an inhibitory Ly49 receptor limits the
expression of endogenous Ly49 receptors in vivo, suggesting
that engagement with self-MHC class I prevents subsequent
expression of new inhibitory receptors during development
(Held and Raulet, 1997). Therefore, there is an as yet undefined
mechanism to ensure that NK cells do not express too many
inhibitory receptors for self-MHC class I (Hanke et al., 2001;
Held and Raulet, 1997; Raulet et al., 1997). Similarly, human
NK cell interactions with self-HLA class I ligands shape the inhib-
itory KIR repertoire in an individual (Shilling et al., 2002; Yawata
et al., 2006, 2008).850 Cell 142, September 17, 2010 ª2010 Elsevier Inc.NK Cell Education Mediated by Self-MHC Class I
and Inhibitory Receptors
An early study reported that all human NK cell clones from two
individuals expressed at least one inhibitory receptor that recog-
nized a self-MHC class I protein, suggesting that a selective
process shaped the NK cell repertoire to maintain tolerance
(Valiante et al., 1997). However, as mentioned above, recent
studies have detected a significant number of mature NK cells
in humans and mice in vivo that do not express any inhibitory
receptors for MHC class I or only express receptors that recog-
nize non-self MHC class I (Fernandez et al., 2005; Yawata et al.,
2008). Additionally, mice lacking surface expression of MHC
class I due to genetic ablation of b2-microglobulin, TAP-1,
and/or MHC class I heavy chains H-2K and H-2D have normal
numbers of mature NK cells and do not exhibit overt NK cell-
mediated autoimmunity.
NK cells developing in the absence of MHC class I are unable
to kill MHC class I-deficient tumor cell lines in vitro and fail to
reject MHC class I-deficient bone marrow in vivo (Bix et al.,
1991; Jonsson and Yokoyama, 2009; Liao et al., 1991). In MHC
class I-sufficient humans or mice, the subset of NK cells lacking
inhibitory receptors for self-MHC class I are hyporesponsive to
in vitro stimulation through several activating receptors and fail
to reject MHC class I-deficient bone marrow in vivo (Anfossi
et al., 2006; Fernandez et al., 2005; Kim et al., 2005). Thus,
expression of self-MHC class I-reactive inhibitory receptors
enhances the responsive potential of NK cells (Anfossi et al.,
2006; Fernandez et al., 2005; Kim et al., 2005) (Figure 2A).
The Basis for NK Cell Inhibition, Education,
and Tolerance
NK cell education requires signaling via the inhibitory receptors
because mutations within the ITIM of inhibitory receptors render
NK cells hyporesponsive even in the presence of the cognate
MHC class I ligand of the mutant receptor (Kim et al., 2005).
Two mechanisms have been proposed to explain this tolerance
of NK cells lacking self-MHC class I. The first hypothesis postu-
lates that NK cells are initially unresponsive or ‘‘unlicensed’’
and that MHC class I engagement of inhibitory receptors
during development licenses or ‘‘arms’’ these cells to become
competent effector cells (Kim et al., 2005). Alternatively, the
‘‘disarming’’ hypothesis suggests that all NK cells are initially
responsive, but if unopposed by MHC class I-specific inhibitory
receptors chronic stimulation by normal cells renders NK cells
anergic (Gasser and Raulet, 2006).
In mixed bone marrow chimeras generated with MHC class
I-sufficient and b2 m-deficient bone marrow, all of the NK cells
were hyporesponsive (Wu and Raulet, 1997). C57BL/6 mice
expressing an H-2Dd transgene are able to reject C57BL/6
bone marrow and kill C57BL/6 lymphoblasts (Johansson et al.,
1997). Although not formally proven, H-2Dd likely educates NK
cells expressing an H-2Dd-specific inhibitory receptor such as
Ly49A or Ly49G2 that would otherwise not be educated by
H-2b. Presumably, NK cells in these transgenic mice that lack
inhibitory receptors for H-2b, but express inhibitory receptors
for H-2Dd, are responsible for rejection of the H-2b C57BL/6
graft. Interestingly, NK cells from a transgenic H-2Dd line that
demonstrated mosaic expression of H-2Dd (that is, H-2Dd was
Figure 2. Models of NK Cell Tolerance
(A) Under homeostatic conditions, interactions between
activating natural killer (NK) receptors and their endoge-
nous ligands render NK cells ‘‘disarmed’’ or anergized.
Engagement of inhibitory receptors by MHC class I
opposes this activation, resulting in ‘‘armed’’ or ‘‘licensed’’
NK cells.
(B) Upon infection with pathogens such as MCMV, all NK
cells become activated and previously anergized NK cells
efficiently control infection. Responding NK cells express-
ing inhibitory receptors are inhibited by self-MHC class I,
preventing optimal responses to infection.
(C) Activated NK cells lacking MHC class I inhibitory
receptors may kill uninfected bystander cells that express
endogenous activating ligands, or alternatively, inhibitory
receptors for self-ligands other than MHC class I may
prevent this autoaggression.only expressed on 10%–80% of hematopoietic cells) were
unable to reject C57BL/6 bone marrow or kill C57BL/6 lympho-
blasts (Johansson et al., 1997). Thus, NK cell education requires
the educatingMHC class I to be expressed on all cells or alterna-
tively hyporesponsiveness is dominantly induced by lack ofMHC
class I, as would be predicted by the disarming hypothesis. The
SHP-1 and SHIP-1 phosphatases associated with inhibitory
receptor signaling are dispensable for NK education, suggesting
that inhibitory signals are not needed for NK cell education, sup-
porting the licensing model (Kim et al., 2005; Orr et al., 2010).
However, these findings are not incompatible with the disarming
model because many inhibitory receptors also associate with
SHP-2, so there might be signaling redundancy between the
different phosphatases recruited by the inhibitory receptors.Cell 1A third ‘‘rheostat’’ model proposes that NK
cell reactivity is tuned by the number of self-
MHC class I inhibitory receptors an NK cell
expresses and by the affinity of each receptor
for self-MHC class I (Brodin et al., 2009; Raulet
and Vance, 2006). NK cells that express two or
more inhibitory receptors for self-MHC class I
respond more frequently and possess stronger
effector functions than NK cells with only one
inhibitory receptor for self-MHC class I (Brodin
et al., 2009; Joncker et al., 2009). The affinity
of the interaction between the inhibitory
receptor and its MHC class I ligand also influ-
ences the NK cell education process (Jonsson
et al., 2010). Thus, NK cell education is likely
to be a quantitative process whereby NK cell
responsive capacity is determined by the
frequency and strength of engagement of inhib-
itory receptors with self-MHC class I, either
opposing chronic activating receptor stimula-
tion (disarming) or by transmitting undefined
activating signals themselves (licensing or
arming). Unlike T cells, there is no evidence for
efficient clonal deletion of potentially autoreac-
tive NK cells either during development in the
bone marrow or in the periphery. Rather, NK
cells lacking self-MHC class I reactive inhibitoryreceptors are maintained in an unresponsive state—at least in
the absence of inflammation or infection.
Inhibitory Receptors Can Bind to MHC Class I
on the Same Cell Surface
In mice, inhibitory receptors appear to be expressed at lower
levels if cognate MHC class I is expressed. This has been inter-
preted as calibrating of the inhibitory receptors to a useful
level (Sentman et al., 1995). Inhibitory Ly49 receptors can,
however, bind to MHC class I expressed on the same cell
surface (binding in cis) as well as binding to MHC class I on other
cells (in trans) (Back et al., 2009; Doucey et al., 2004; Scarpellino
et al., 2007). Disrupting cis interactions restores apparent
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class I-deficient NK cells, providing evidence against the calibra-
tion model, rather implying that cis interactions simply mask the
antibody-binding site necessary to detect the inhibitory Ly49
receptor (Doucey et al., 2004). These cis interactions have
been proposed to mediate NK cell licensing because mutant
inhibitory receptors incapable of cis interactions are unable to
engender NK cell responsiveness (Chalifour et al., 2009).
However, results from mixed wild-type and b2 m-deficient
bone marrow chimeras demonstrate that disarming of wild-
type NK cells is dominant in the chimeras and is induced in trans,
thus arguing against licensing in cis (Wu and Raulet, 1997). Cis
interactions do prevent inhibitory receptor recruitment to the
immunological synapse, thus reducing the inhibitory potential
of these receptors (Andersson et al., 2007; Doucey et al., 2004).
Breaking NK Cell Anergy and Tolerance
Just as anergized or exhausted T cells can often regain function-
ality by ex vivo cytokine stimulation or by blocking the tolerizing
signal (Barber et al., 2006; Teague et al., 2006), functionality of
unlicensed or disarmed NK cells can be restored. This restora-
tion of function can be accomplished in a number of ways,
including in vitro culture with interleukin-2 (IL-2) or with IL-12
and IL-18, strong stimulation via activating receptors in vitro,
or infection with Listeria monocytogenes or MCMV in vivo
(Fernandez et al., 2005; Johansson et al., 1997; Kim et al.,
2005; Orr et al., 2010; Sun and Lanier, 2008a; Yokoyama and
Kim, 2006). After MCMV infection, licensed and unlicensed NK
cells, as defined by self-MHC class I inhibitory receptor expres-
sion, both express the early activation antigen CD69 and
equivalently upregulate effector molecules such as interferon-g
(IFN-g) and granzyme B (Orr et al., 2010). This early activation
is driven by the inflammatory environment associated with infec-
tion and is independent of cognate activating receptor engage-
ment. During MCMV infection NK cells in C57BL/6 mice undergo
a proliferative burst, driven by the activating Ly49H receptor
engaging its cognate ligand, the MCMV-encoded glycoprotein
m157, which is expressed on the surface of infected cells (Dokun
et al., 2001). Expression of inhibitory receptors for self-MHC
class I restrain the proliferation of licensed NK cells, whereas in
NK cells lacking self-MHC reactive inhibitory receptors prolifera-
tion proceeds unimpeded (Orr et al., 2010). This restraint of
proliferation by inhibitory receptors is mediated by SHP-1 phos-
phatase signaling. NK cells are critical for controlling MCMV viral
titers and pathogenesis, yet depletion of licensed NK cells does
not negatively affect control of MCMV. Similarly, adoptive trans-
fer of unlicensed, but not licensed, NK cells is sufficient to
protect neonates against MCMV challenge (Orr et al., 2010).
Thus, when NK cells need to directly interact with virus-infected
cells to control the infection, inhibitory receptors for MHC class I
impair, rather than license, NK cell functions (Figure 2B).
In mixed bone marrow chimeric mice containing b2 m-defi-
cient and wild-type hematopoietic cells, the NK cell tolerance
demonstrated by the wild-type NK cells can also be broken
during viral infection. In these chimeric mice, b2 m-deficient
hematopoietic cells, which were largely tolerated for weeks or
months, are rapidly eliminated by NK cells after viral infection
(Sun and Lanier, 2008a). Rejection of the b2 m-deficient cells in
thesemixed chimeric mice does not require that they be infected852 Cell 142, September 17, 2010 ª2010 Elsevier Inc.with the virus. Similarly, when NK cells lacking expression of
H-2Dd are removed from the transgenic mice displaying mosaic
expression of H-2Dd and cultured in vitro in IL-2, tolerance to
H-2Dd is lost and these NK cells are capable of attacking and
killing target cells expressing H-2Dd (Johansson et al., 1997).
NK cell anergy in response to chronic stimulation to m157 could
be reversed if the Ly49H-expressing NK cells are removed from
the m157 transgenic mice, indicating that anergy requires sus-
tained exposure to the activating ligand (Tripathy et al., 2008).
Collectively, these findings reveal that NK cell tolerance or
anergy is reversible and broken in the presence of inflammatory
cytokines or infection.
NK Cell Inhibitory Receptors and Control of Human
Leukemias
In human leukemia patients receiving irradiation therapy fol-
lowed by bone marrow transplantation, donor NK cells can
play a critical role in eliminating residual leukemic cells and pre-
venting rejection of the donor bone marrow by killing recipient
antigen-presenting cells that normally prime allogeneic T cell
responses. In T cell-depleted, HLA-matched, but KIR-mis-
matched bone marrow transplants (in which not all donor-
derived NK cells are inhibited by the recipient HLA or educated
by donor or recipient HLA), the number of inhibitory KIR–HLA
mismatches (that is, missing inhibitory ligands in the recipient)
correlates with positive outcomes, including fewer leukemic
relapses and improved graft acceptance (Clausen et al., 2007;
Hsu et al., 2005; Sobecks et al., 2007; Symons et al., 2010).
Donor-derived NK cells in the bone marrow recipient that are
unlicensed (that is, do not express KIR reactive with donor or
recipient HLA class I) ex vivo express high levels of IFN-g and
are competent to kill target cells, indicating that they are acti-
vated effector cells (Yu et al., 2009). Reciprocally, in HLA-
mismatched, T cell-depleted bone marrow grafts, positive
outcomes correlate with lack of HLA ligands in the recipient for
inhibitory KIRs on donor-derived NK cells (Miller et al., 2007;
Ruggeri et al., 2002). Thus, in the case of NK cell-mediated
graft-versus-leukemia, expression of inhibitory KIRs on donor-
derived NK cells that are reactive with recipient HLA limited the
effectiveness of donor NK cells in clearing leukemias and
promoting graft acceptance (Yokoyama et al., 2010).
NK Cell Inhibitory Receptors in Immune Defense
In the absence of infection or inflammation, NK cells that
possess inhibitory receptors for self-MHC class I are more
responsive to stimulation than NK cells lacking self-MHC class
I inhibitory receptors. Under what circumstances might these
NK cells with self-MHC class I receptors provide benefit to the
host? One scenario would be when host cells become trans-
formed and downregulate MHC class I expression due to
chromosomal instability that results in the loss of b2 m, TAP-1,
or MHC class I heavy chain genes. The ability of healthy mice
to reject transplanted cells from syngeneic b2 m-deficient mice
clearly demonstrates that as yet undefined ligands for activating
NK receptors are present on nontransformed host cells, but NK
cell attack is being prevented by the inhibitory receptors for self-
MHC class I. Although not yet experimentally demonstrated, the
NK cells that possess inhibitory receptors for self-MHC class I
Table 2. NK Cell Inhibitory Receptors
Gene Common Name Species Ligand
Klra1, 3, 7, 9 Ly49A, C, G2, I Mouse Various H-2 class I
Klrb1b, d NKR-P1B, D Mouse Ocil (Clr-b)
Lilrb4 gp49b1 Mouse avb3
Pilra PILRa Mouse O-glycosylated
CD99
SIGLEC-E Mouse Sialic acid
CD244 2B4 Mouse CD48
KLRG1 Mafa Mouse,
human
E-, N-, R- cadherins
KLRD1-KLRC1 CD94-NKG2A Mouse,
human
Mouse Qa-1b,
Human HLA-E
KLRB1 NKR-P1A, CD161 Human LLT1 (CLEC2D)
LAIR1 LAIR-1, CD305 Human,
mouse
Collagen XVII
LILRB1 ILT2, LIR1, CD85j Human HLA class I
KIR2DL1-3, 5 CD158 Human HLA-C
KIR3DL1, 2 CD158 Human HLA-Bw4,
some HLA-A
CEACAM1 CD66a Human CD66
SIGLEC7 CDw328 Human Ganglioside GD3
SIGLEC9 Human Sialic acidmight provide for ‘‘missing-self’’ detection and elimination of
nascent tumors.
Another scenario whereby NK cells that possess inhibitory
receptors for self-MHC class I might be beneficial is in sparing
MHC class I-expressing dendritic cells from attack by NK cells
during an infection. In the absence of NK cells or in mice lacking
the Ly49H receptor, a stronger T cell response is mounted
against MCMV infection. This may be due to a robust early NK
cell response that eliminates MCMV-infected dendritic cells,
thus decreasing priming of MCMV-specific T cells (Andrews
et al., 2010; Su et al., 2001). Although not tested in this study,
it is possible that dendritic cells are preferentially killed by
Ly49H+ NK cells lacking self-MHC class I inhibitory receptors.
Thus, by restraining NK cell responses, inhibitory receptors
might contribute to better overall control of infection by permit-
ting more robust T cell priming.
What Prevents Autoimmunity Mediated by NK Cells?
In steady-state conditions, NK cells lacking self-MHC class I
inhibitory receptors might simply be anergized by chronic stimu-
lation through their unknown activating receptors engaging
ligands on normal cells and tissues. However, both in vivo and
in vitro these NK cells can be activated by cytokines or infection
and mediate potent effector functions. What then might regulate
their attack against normal, healthy cells or tissues? In addition
to inhibitory receptors for MHC class I, NK cells express several
other inhibitory receptors that recognize ligands not encoded by
MHC genes (Kumar and McNerney, 2005) (Table 2). Many of
these inhibitory receptors are expressed constitutively on most
NK cells. For example, mouse 2B4 (CD244) recognizes the
ubiquitously expressed CD48 glycoprotein, human NKR-P1A(CD161) recognizes the LLT1 ligand on activated B cells and
dendritic cells, and human and mouse LAIR-1 (CD305) recog-
nizes collagen. Other receptors such as KLRG1 that recognizes
cadherins and gp49B1 that recognizes the avb3 integrin are
upregulated on activated NK cells during viral infection (Robbins
et al., 2004; Wang et al., 2000). The role of these inhibitory
receptors in shaping NK cell tolerance and functionality is
largely unexplored, particularly in regulating the subset of NK
cells lacking self-MHC class I inhibitory receptors. Thus, these
inhibitory receptors might prevent NK cell-driven autoimmunity.
Alternatively, elimination of uninfected cells (bystander killing) by
NK cells lacking MHC class I-reactive inhibitory receptors might
be an evolutionarily acceptable trade-off for the enhanced
control of infections (Figure 2C).
Outstanding Questions
Although NK cells have been studied for more than 30 years and
many of their receptors and signaling pathways have been iden-
tified, the molecular basis of NK cell tolerance remains unde-
fined. Strikingly, we still do not know the physiological relevance
of ‘‘missing self’’ surveillance in the host. Anothermajor unsolved
question is how NK cells lacking self-reactive MHC class I inhib-
itory receptors can functionally mature and acquire lytic effector
molecules yet remain tolerant of their environment. Finally, the
mechanisms inducing tolerance upon chronic exposure to acti-
vating ligands are undefined. These and many other questions
need to be answered before we can fully understand NK cell
development, education, and tolerance.
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